Please login to the form below

Not currently logged in
Email:
Password:

global access

This page shows the latest global access news and features for those working in and with pharma, biotech and healthcare.

Despite FDA concerns, Akcea rare disease drug clears FDA panel

Despite FDA concerns, Akcea rare disease drug clears FDA panel

Earlier this week, Akcea, a subsidiary of Ionis, announced that it would be expanding its global early access programme (EAP) for volanesorsen to the US.

Latest news

  • Pfizer takes aim at UK’s health tech industry Pfizer takes aim at UK’s health tech industry

    The successful start-ups will benefit from access to Pfizer’s network of global partners, including the NHS. ... Dr Hamish Graham, manager for Pfizer Healthcare Hub: London, said: “The healthcare hub will provide a platform for start-ups to harness

  • Alex Butler and Matt Baker launch Foundry3 Alex Butler and Matt Baker launch Foundry3

    Before moving agency-side in 2011, he spent more than a decade within pharma, including six years at J&J in various market access, marketing, communications and digital strategy roles. ... Blackmore said: “Being part of bmore means Foundry. 3. can

  • The power of pharma businesses to drive social change The power of pharma businesses to drive social change

    Astellas believes that we are better together, and is therefore a member of Access Accelerated, a global partnership, bringing together 20 biopharma firms and associations. ... The products we produce are fundamental in the treatment offered to patients,

  • Amgen signs real world study and mobile data partnership Amgen signs real world study and mobile data partnership

    Joshua Ofman, Amgen's senior vice president of global value, access and policy, said: “The rising cost of disease is challenging the sustainability of our health care system in the US

  • Facing the new wave of biosimilars Facing the new wave of biosimilars

    As an organisation that represents clinicians and patients, the Global Alliance for Patient Access (GAfPA) closely follows the debate. ... GAfPA campaigns across Europe to ensure patient access to appropriate clinically approved therapies.

More from news
Approximately 0 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    For Lars the change is newer still as he only moved from Berlin to Reading in September 2017, swapping his role as head of global market access at Bayer Pharma for ... From the perspective of your previous global market access role, in which country did

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    They were gathering as much data as possible - global, local, whatever they have access to, to predict what their clinical trial process would look like. ... We all agreed that such platforms are invaluable for:. Granting better access to patients.

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    Furthermore, not all of these technologies would necessarily complete the Accelerated Access Pathway. ... is an independent global market access consultant. 18th January 2017.

  • Going fully digital Going fully digital

    For instance, 85% of respondents said they lack the ability to report on content status and process bottlenecks, while 75% reported missing global digital asset management (DAM) systems. ... And because the content management solution is in the cloud,

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today.

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

  • Greg Perry joins IFPMA as assistant director general Greg Perry joins IFPMA as assistant director general

    Perry, who was most recently executive director of the Medicines Patent Pool in Geneva, will move to the global industry body in February. ... At the IFPMA he will have responsibility for its external outreach and stakeholder engagement on global health

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    was head of the pharma group’s global market access business. ... Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global

  • Ashfield appoints new leaders in the US and Japan Ashfield appoints new leaders in the US and Japan

    in a role that will see him deliver commercial, clinical, pharmacovigilance and market access operations. ... Tompkins added: “ The appointment of Mick O’Leary as regional president in Japan will continue our success story and excellent results in

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... Wheatley Price joins Takeda from GlaxoSmithKline, where he

  • GalbraithWight appoints Eithne McShane and Steve Mazzarese GalbraithWight appoints Eithne McShane and Steve Mazzarese

    They join the market access consultancy as global business development directors. ... In her new role at UK-based market access consultancy she will be tasked with growing GalbraithWight's business with global and regional clients located in Europe.

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Market Access Transformation

    available. Rapid Payer Response specializes in creating new technologies that allow pharmaceutical companies and manufacturers get feedback and insight on demand from a network of global, expert payers. ... Board Vice Chairman. View LinkedIn profile.

  • Curo

    We are a global Pharma Market Access consultancy, with the core belief in adopting a collaborative approach to Payer engagement.

  • Valid Insight

    Valid Insight is a specialist global market access consultancy. With a team that includes some of the world’s leading market access and pricing experts, our clients trust us to help ... We focus on pricing, market access and value communication

  • Medical Media Communications

    MMC Scientific is the dedicated medical communications agency of The Radcliffe Group Ltd, affiliated to Radcliffe Cardiology, granting access to its global database of 65, 000+ cardiologists worldwide.

  • GCI Health

    Our talented team delivers the commitment, passion and entrepreneurial spirit of a specialist agency while providing our client partners access to a genuine and active global network. ... PRWeek (Global)  – Global PR Breakthrough (WINNER). PRWeek (UK)

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics